glp 1 switzerland Obesity drug cuts opiate craving | Science 🚨Swissmedic issues warning against falsified
Description
The British biotech was nominated as one of 2025s Fierce 15 biotechnology companies in September, the only one in the ranks to have been founded in 2025
Injectable GLP-1 receptor agonists such as semaglutide, liraglutide and exenatide have transformed care, but the shift toward oral alternatives points to a wider opportunity: creating solid oral dosage forms that improve patient experience without compromising performance
However, LifeRx.md was designed to make medical weight loss accessible to everyoneno insurance required
Anyone thinking about taking them or experiencing side effects should consult with a primary care provider or another trusted health care provider to understand the risks
People with diabetes have had a hard time getting ahold of their medications because of the shortages, with some rationing their drugs to cope with the lack of supply, NPR reported
